| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 9.37e-05 | 16 | 113 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 9.49e-05 | 3 | 113 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.18e-04 | 21 | 113 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | activin receptor activity, type I | 3.14e-04 | 5 | 113 | 2 | GO:0016361 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 4.37e-04 | 316 | 113 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RERG DNAH3 MYO18A AGAP11 FANCM ABCA7 EEF2 MDN1 MTIF2 DDX23 KIF13A MOV10 AGAP2 | 4.41e-04 | 775 | 113 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.59e-04 | 118 | 113 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RERG DNAH3 MYO18A AGAP11 FANCM ABCA7 EEF2 MDN1 MTIF2 DDX23 KIF13A MOV10 AGAP2 | 9.22e-04 | 839 | 113 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RERG DNAH3 MYO18A AGAP11 FANCM ABCA7 EEF2 MDN1 MTIF2 DDX23 KIF13A MOV10 AGAP2 | 9.32e-04 | 840 | 113 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RERG DNAH3 MYO18A AGAP11 FANCM ABCA7 EEF2 MDN1 MTIF2 DDX23 KIF13A MOV10 AGAP2 | 9.32e-04 | 840 | 113 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | phospholipid binding | ARHGAP32 FRMPD4 INPPL1 NUMA1 AGAP11 SNX16 SNX30 MYOF SNX7 PLEKHA5 | 1.11e-03 | 548 | 113 | 10 | GO:0005543 |
| GeneOntologyMolecularFunction | activin receptor activity | 1.11e-03 | 9 | 113 | 2 | GO:0017002 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.38e-03 | 85 | 113 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.38e-03 | 85 | 113 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.39e-03 | 39 | 113 | 3 | GO:0070325 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ARHGAP32 FRMPD4 PDGFRB HYAL1 SRC NUMA1 MYO18A CKAP5 PIWIL2 RET ABCA7 TGFBR1 SNX30 SETDB1 SNX7 ANAPC2 LRP1 LRP2 PRKCA TNKS2 ADGRL2 | 9.56e-06 | 1366 | 110 | 21 | GO:0051130 |
| GeneOntologyCellularComponent | myosin filament | 8.74e-06 | 25 | 111 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | dendrite | ARHGAP32 MYH10 FRMPD4 SRC NUMA1 CKAP5 BRINP1 RET LRP1 LRP2 ARC PRKCA AGAP2 GABRA5 | 1.81e-04 | 858 | 111 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ARHGAP32 MYH10 FRMPD4 SRC NUMA1 CKAP5 BRINP1 RET LRP1 LRP2 ARC PRKCA AGAP2 GABRA5 | 1.85e-04 | 860 | 111 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | activin receptor complex | 4.13e-04 | 6 | 111 | 2 | GO:0048179 | |
| GeneOntologyCellularComponent | myosin II complex | 4.33e-04 | 28 | 111 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | dense body | 5.77e-04 | 7 | 111 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ARHGAP32 KLHL24 MYH10 FRMPD4 SRC NUMA1 CKAP5 BRINP1 RET LRP1 LRP2 ARC PRKCA USH2A AGAP2 GABRA5 | 7.59e-04 | 1228 | 111 | 16 | GO:0036477 |
| Domain | - | 7.99e-06 | 46 | 112 | 5 | 4.10.400.10 | |
| Domain | LDrepeatLR_classA_rpt | 1.10e-05 | 49 | 112 | 5 | IPR002172 | |
| Domain | LDLa | 1.10e-05 | 49 | 112 | 5 | SM00192 | |
| Domain | DUF5050 | 3.56e-05 | 2 | 112 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.56e-05 | 2 | 112 | 2 | PF16472 | |
| Domain | P-loop_NTPase | RERG DNAH3 MYH10 MYH11 MYO18A CARD10 CHST1 FANCM ABCA7 EEF2 MDN1 MTIF2 DDX23 KIF13A MOV10 AGAP2 | 4.53e-05 | 848 | 112 | 16 | IPR027417 |
| Domain | Ldl_recept_b | 7.28e-05 | 14 | 112 | 3 | PF00058 | |
| Domain | LDLRB | 7.28e-05 | 14 | 112 | 3 | PS51120 | |
| Domain | LY | 9.06e-05 | 15 | 112 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 9.06e-05 | 15 | 112 | 3 | IPR000033 | |
| Domain | LDLR_class-A_CS | 9.48e-05 | 40 | 112 | 4 | IPR023415 | |
| Domain | Fatty_acid_desaturase | 1.07e-04 | 3 | 112 | 2 | IPR012171 | |
| Domain | Ldl_recept_a | 1.51e-04 | 45 | 112 | 4 | PF00057 | |
| Domain | Myosin_tail_1 | 1.60e-04 | 18 | 112 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.60e-04 | 18 | 112 | 3 | IPR002928 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.65e-04 | 46 | 112 | 4 | IPR011042 | |
| Domain | Myosin-like_IQ_dom | 1.90e-04 | 19 | 112 | 3 | IPR027401 | |
| Domain | - | 1.90e-04 | 19 | 112 | 3 | 4.10.270.10 | |
| Domain | LDLRA_1 | 1.95e-04 | 48 | 112 | 4 | PS01209 | |
| Domain | PX | 2.11e-04 | 49 | 112 | 4 | PF00787 | |
| Domain | LDLRA_2 | 2.11e-04 | 49 | 112 | 4 | PS50068 | |
| Domain | PX | 2.28e-04 | 50 | 112 | 4 | PS50195 | |
| Domain | - | 2.46e-04 | 51 | 112 | 4 | 3.30.1520.10 | |
| Domain | Phox | 2.66e-04 | 52 | 112 | 4 | IPR001683 | |
| Domain | Myosin_S1_N | 3.52e-04 | 5 | 112 | 2 | IPR008989 | |
| Domain | cEGF | 4.94e-04 | 26 | 112 | 3 | PF12662 | |
| Domain | cEGF | 4.94e-04 | 26 | 112 | 3 | IPR026823 | |
| Domain | - | RERG DNAH3 MYO18A CARD10 CHST1 FANCM ABCA7 EEF2 MDN1 MTIF2 DDX23 MOV10 AGAP2 | 5.28e-04 | 746 | 112 | 13 | 3.40.50.300 |
| Domain | Anoct_dimer | 7.34e-04 | 7 | 112 | 2 | PF16178 | |
| Domain | Anoct_dimer | 7.34e-04 | 7 | 112 | 2 | IPR032394 | |
| Domain | GS_dom | 7.34e-04 | 7 | 112 | 2 | IPR003605 | |
| Domain | GS | 7.34e-04 | 7 | 112 | 2 | PS51256 | |
| Domain | TGF_beta_GS | 7.34e-04 | 7 | 112 | 2 | PF08515 | |
| Domain | GS | 7.34e-04 | 7 | 112 | 2 | SM00467 | |
| Domain | FA_desaturase_dom | 9.75e-04 | 8 | 112 | 2 | IPR005804 | |
| Domain | FA_desaturase | 9.75e-04 | 8 | 112 | 2 | PF00487 | |
| Domain | Myosin_head_motor_dom | 1.52e-03 | 38 | 112 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.52e-03 | 38 | 112 | 3 | PS51456 | |
| Domain | Myosin_head | 1.52e-03 | 38 | 112 | 3 | PF00063 | |
| Domain | MYSc | 1.52e-03 | 38 | 112 | 3 | SM00242 | |
| Domain | Anoctamin | 1.55e-03 | 10 | 112 | 2 | PF04547 | |
| Domain | Anoctamin | 1.55e-03 | 10 | 112 | 2 | IPR007632 | |
| Domain | Activin_recp | 1.55e-03 | 10 | 112 | 2 | PF01064 | |
| Domain | Activin_recp | 1.55e-03 | 10 | 112 | 2 | IPR000472 | |
| Domain | - | 1.64e-03 | 39 | 112 | 3 | 2.120.10.30 | |
| Domain | TGFB_receptor | 2.26e-03 | 12 | 112 | 2 | IPR000333 | |
| Domain | Quinoprot_gluc/sorb_DH | 2.26e-03 | 12 | 112 | 2 | IPR011041 | |
| Domain | PX | 2.32e-03 | 44 | 112 | 3 | SM00312 | |
| Domain | CYTOCHROME_B5_2 | 2.66e-03 | 13 | 112 | 2 | PS50255 | |
| Domain | CYTOCHROME_B5_1 | 2.66e-03 | 13 | 112 | 2 | PS00191 | |
| Domain | ATPase_dyneun-rel_AAA | 3.09e-03 | 14 | 112 | 2 | IPR011704 | |
| Domain | Cyt-b5 | 3.09e-03 | 14 | 112 | 2 | PF00173 | |
| Domain | - | 3.09e-03 | 14 | 112 | 2 | 3.10.120.10 | |
| Domain | Cyt_B5-like_heme/steroid-bd | 3.09e-03 | 14 | 112 | 2 | IPR001199 | |
| Domain | Cyt-b5 | 3.09e-03 | 14 | 112 | 2 | SM01117 | |
| Domain | AAA_5 | 3.09e-03 | 14 | 112 | 2 | PF07728 | |
| Domain | WW_DOMAIN_1 | 3.55e-03 | 51 | 112 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 3.55e-03 | 51 | 112 | 3 | PS50020 | |
| Domain | Myosin_N | 3.56e-03 | 15 | 112 | 2 | PF02736 | |
| Domain | Myosin_N | 3.56e-03 | 15 | 112 | 2 | IPR004009 | |
| Domain | WW_dom | 3.75e-03 | 52 | 112 | 3 | IPR001202 | |
| Domain | PH_dom-like | 4.14e-03 | 426 | 112 | 8 | IPR011993 | |
| Domain | EGF_1 | 4.38e-03 | 255 | 112 | 6 | PS00022 | |
| Domain | EFTu-like_2 | 5.12e-03 | 18 | 112 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 5.12e-03 | 18 | 112 | 2 | PF03144 | |
| Domain | G_TR_2 | 5.12e-03 | 18 | 112 | 2 | PS51722 | |
| Domain | Gal_Oxase/kelch_b-propeller | 5.35e-03 | 59 | 112 | 3 | IPR011043 | |
| Domain | TF_GTP-bd_dom | 5.70e-03 | 19 | 112 | 2 | IPR000795 | |
| Pubmed | RANBP2 MYH10 MYH11 ZSWIM5 MTRES1 KTN1 NUMA1 MYO18A FAM47B CXXC1 NUP205 EEF2 MDN1 SND1 DDX23 ATG4C MYOM2 TOP1MT CCDC191 AGAP2 | 4.62e-08 | 1442 | 114 | 20 | 35575683 | |
| Pubmed | ARHGAP32 RANBP2 MYH10 ZSCAN12 KTN1 SRC NUMA1 CKAP5 ZMYM2 EEF2 MDN1 LRP1 ARC PRKCA PLEKHA5 AGAP2 | 1.08e-07 | 963 | 114 | 16 | 28671696 | |
| Pubmed | ARHGAP32 RANBP2 MYH10 MYH11 KTN1 SRC MYO18A ZMYM2 SETDB1 PLEKHA5 GAREM1 | 6.26e-07 | 486 | 114 | 11 | 20936779 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.59e-06 | 332 | 114 | 9 | 32786267 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NDUFB11 HSPG2 KTN1 APEX1 PTDSS2 LRP1B ABCA7 TMX2 TGFBR1 MYOF EEF2 LRP1 FADS2 UHRF1 PLEKHA5 PRKCSH | 1.99e-06 | 1201 | 114 | 16 | 35696571 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 MYH10 UBE4B KTN1 NUMA1 CKAP5 CXXC1 NUP205 EEF2 MDN1 SND1 DDX23 PRKCA PLEKHA5 RPL22L1 CORO7 MOV10 | 2.04e-06 | 1353 | 114 | 17 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 MYH10 EPPK1 KTN1 MYO18A CKAP5 APEX1 NUP205 SETDB1 MYOF EEF2 SND1 LRP1 FADS2 PRKCA PRKCSH ALDH5A1 | 2.34e-06 | 1367 | 114 | 17 | 32687490 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 EPPK1 UBE4B WWP1 INPPL1 CARD10 ABCA7 SNX30 MYOF MDN1 SND1 ARC PCNX1 DISP2 GAREM1 | 3.42e-06 | 1105 | 114 | 15 | 35748872 |
| Pubmed | 5.30e-06 | 35 | 114 | 4 | 24515614 | ||
| Pubmed | HSPG2 ARHGAP32 IFFO1 WWP1 MYO18A TNS2 CXXC1 SETDB1 LRP2 FADS2 PLEKHA5 | 5.39e-06 | 608 | 114 | 11 | 16713569 | |
| Pubmed | 5.55e-06 | 11 | 114 | 3 | 24639464 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.38e-06 | 394 | 114 | 9 | 27248496 | |
| Pubmed | 8.28e-06 | 407 | 114 | 9 | 12693553 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | NDUFB11 RANBP2 ZSCAN12 UBE4B PDGFRB KTN1 CKAP5 ZMYM2 NUP205 TMX2 EEF2 FADS3 ICMT LRP1 FADS2 | 9.44e-06 | 1203 | 114 | 15 | 29180619 |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 10070972 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18524994 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24861944 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.07e-05 | 2 | 114 | 2 | 15963947 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 10850414 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 12235291 | ||
| Pubmed | Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue. | 1.07e-05 | 2 | 114 | 2 | 10906735 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 15944146 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 15272003 | ||
| Pubmed | Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival. | 1.07e-05 | 2 | 114 | 2 | 14766744 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23882690 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 7916668 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 22308030 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 16316347 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 19006078 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 34445520 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9010229 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 20929586 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 28237083 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 17724468 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 30228226 | ||
| Pubmed | Molecular mechanism underlying the association of Coronin-7 with Golgi membranes. | 1.07e-05 | 2 | 114 | 2 | 18581049 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18315570 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 2996780 | ||
| Pubmed | 1.22e-05 | 14 | 114 | 3 | 15082773 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH10 MYH11 EPPK1 KTN1 NUMA1 APEX1 MYOF EEF2 MDN1 SND1 PCNX1 PRKCSH | 1.43e-05 | 807 | 114 | 12 | 30575818 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH10 MYH11 EPPK1 FRMPD4 NUMA1 MYO18A EEF2 SND1 UHRF1 DDX23 RPL22L1 TOP1MT MOV10 | 1.46e-05 | 949 | 114 | 13 | 36574265 |
| Pubmed | 1.72e-05 | 340 | 114 | 8 | 24332808 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 2.03e-05 | 100 | 114 | 5 | 25807483 | |
| Pubmed | UBE4B PDGFRB CKAP5 ZMYM2 LRP1B TRIM5 SETDB1 EEF2 MTIF2 LGI3 LRP1 LRP2 TNKS2 ALDH5A1 AGAP2 | 2.04e-05 | 1285 | 114 | 15 | 35914814 | |
| Pubmed | ARHGAP32 RANBP2 MYH10 FRMPD4 KTN1 MYO18A CKAP5 NDUFA6 LRP1B FADS2 PRKCA ALDH5A1 AGAP2 GABRA5 | 2.24e-05 | 1139 | 114 | 14 | 36417873 | |
| Pubmed | 2.26e-05 | 17 | 114 | 3 | 37072811 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.49e-05 | 358 | 114 | 8 | 32460013 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 2.89e-05 | 477 | 114 | 9 | 31300519 | |
| Pubmed | GCNT3 WWP1 SRC LRP1B MTMR7 MAPK12 LRP1 LRP2 PCSK7 PRKCA CES4A | 2.94e-05 | 730 | 114 | 11 | 34857952 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 3.04e-05 | 268 | 114 | 7 | 33024031 | |
| Pubmed | Placental expression of Fatty Acid Desaturases 1, 2 and 3 in selected pregnancy pathologies. | 3.19e-05 | 3 | 114 | 2 | 36652541 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17974965 | ||
| Pubmed | Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors. | 3.19e-05 | 3 | 114 | 2 | 23883001 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 16973711 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 18814181 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 34729648 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 10860662 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 27151458 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 22532564 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 25158168 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 15753096 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 12789267 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 22877655 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 19369415 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 19742316 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 21040914 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 24985009 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 18950621 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 36791912 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 27269715 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17158602 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 15583006 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23922991 | ||
| Pubmed | Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110. | 3.19e-05 | 3 | 114 | 2 | 15314167 | |
| Pubmed | Src-dependent autophagic degradation of Ret in FAK-signalling-defective cancer cells. | 3.19e-05 | 3 | 114 | 2 | 22732841 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 24860093 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 33998651 | ||
| Pubmed | MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing. | 3.19e-05 | 3 | 114 | 2 | 19066283 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 3.26e-05 | 372 | 114 | 8 | 22939624 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 4.11e-05 | 281 | 114 | 7 | 28706196 | |
| Pubmed | 4.36e-05 | 503 | 114 | 9 | 16964243 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 4.37e-05 | 21 | 114 | 3 | 21337463 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RANBP2 MYH10 MYH11 EPPK1 MYO18A TRIM5 EEF2 MDN1 PRKCSH MOV10 | 5.56e-05 | 647 | 114 | 10 | 26618866 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.65e-05 | 202 | 114 | 6 | 33005030 | |
| Pubmed | 5.65e-05 | 202 | 114 | 6 | 24639526 | ||
| Pubmed | 5.79e-05 | 23 | 114 | 3 | 20468071 | ||
| Pubmed | 5.79e-05 | 23 | 114 | 3 | 33315499 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 5.80e-05 | 203 | 114 | 6 | 22083510 | |
| Pubmed | 6.01e-05 | 653 | 114 | 10 | 22586326 | ||
| Pubmed | MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling. | 6.36e-05 | 4 | 114 | 2 | 27259262 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 12413896 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 20562440 | ||
| Pubmed | Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer. | 6.36e-05 | 4 | 114 | 2 | 32958674 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 7775583 | ||
| Pubmed | TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target. | 6.36e-05 | 4 | 114 | 2 | 32694521 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 32513819 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 23651497 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 28751768 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 21335603 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 12739008 | ||
| Interaction | SHC1 interactions | ARHGAP32 MYH10 MYH11 PDGFRB INPPL1 SRC RET EEF2 LRP1 PRKCA MOV10 GAREM1 | 1.00e-06 | 362 | 114 | 12 | int:SHC1 |
| Interaction | RAC1 interactions | ARHGAP32 ARHGAP15 PDGFRB INPPL1 KTN1 SRC MYO18A BRINP1 NUP205 TGFBR1 MYOF EEF2 MDN1 SEMA6D ICMT LRP2 PRKCA PLEKHA5 ADGRL2 AGAP2 | 1.98e-06 | 1063 | 114 | 20 | int:RAC1 |
| Interaction | ITGB3 interactions | 5.60e-06 | 170 | 114 | 8 | int:ITGB3 | |
| Interaction | HSP90AA1 interactions | HSPG2 PDGFRB WWP1 KTN1 EGLN1 SRC NUMA1 PTDSS2 PIWIL2 RET ACVR1C CXXC1 TGFBR1 SETDB1 EEF2 SND1 ANAPC2 LRP1 UHRF1 PRKCA PRKCSH | 7.33e-06 | 1263 | 114 | 21 | int:HSP90AA1 |
| Interaction | GRIN2A interactions | 1.47e-05 | 93 | 114 | 6 | int:GRIN2A | |
| GeneFamily | Low density lipoprotein receptors | 2.97e-05 | 13 | 87 | 3 | 634 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 3.59e-04 | 29 | 87 | 3 | 754 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 4.73e-04 | 7 | 87 | 2 | 345 | |
| GeneFamily | Fatty acid desaturases | 6.29e-04 | 8 | 87 | 2 | 553 | |
| GeneFamily | Tudor domain containing | 7.43e-04 | 37 | 87 | 3 | 780 | |
| GeneFamily | Anoctamins | 1.00e-03 | 10 | 87 | 2 | 865 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.46e-03 | 12 | 87 | 2 | 1290 | |
| GeneFamily | Myosin heavy chains | 2.31e-03 | 15 | 87 | 2 | 1098 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.97e-03 | 17 | 87 | 2 | 1291 | |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | ANO4 CLN8 KLHL24 UBE4B KTN1 TNS2 SNX30 MTMR7 LGI3 PCSK7 ATG4C PRKCSH KIF13A FAIM2 GAREM1 | 9.89e-07 | 754 | 114 | 15 | M39037 |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-07 | 177 | 114 | 7 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-07 | 177 | 114 | 7 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.74e-07 | 177 | 114 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-07 | 184 | 114 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-07 | 184 | 114 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-07 | 184 | 114 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.86e-07 | 184 | 114 | 7 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.41e-07 | 187 | 114 | 7 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.22e-07 | 199 | 114 | 7 | cefc3b50f65e95da850e4720c7b44bf584073491 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.22e-07 | 199 | 114 | 7 | aaa460c389cd6d38a13ba1a446f91a94f9573ad8 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 8.50e-07 | 200 | 114 | 7 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.99e-06 | 175 | 114 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-06 | 181 | 114 | 6 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.26e-06 | 181 | 114 | 6 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 7.73e-06 | 183 | 114 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.48e-06 | 186 | 114 | 6 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 187 | 114 | 6 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.74e-06 | 187 | 114 | 6 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 187 | 114 | 6 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 187 | 114 | 6 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.01e-06 | 188 | 114 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 9.29e-06 | 189 | 114 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.29e-06 | 189 | 114 | 6 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.86e-06 | 191 | 114 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.86e-06 | 191 | 114 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 9.86e-06 | 191 | 114 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 192 | 114 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 192 | 114 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 192 | 114 | 6 | 88472b99970ba0decbf87164fc241a1c77b3b389 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 192 | 114 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | LAM-LAM-LAM+|LAM / Condition, Lineage and Cell class | 1.08e-05 | 194 | 114 | 6 | 4ba73a9145ed44896e359f6df9c1f32bbe24a189 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 194 | 114 | 6 | 52ecec2618c3bb5fdd7fb06b5a40bd6f0aedfe1d | |
| ToppCell | LAM-LAM|LAM / Condition, Lineage and Cell class | 1.08e-05 | 194 | 114 | 6 | 4c6561a64711c72c4ef4a3e67c41d2e8d31fba57 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.08e-05 | 194 | 114 | 6 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 194 | 114 | 6 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 195 | 114 | 6 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 195 | 114 | 6 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 197 | 114 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 198 | 114 | 6 | 85215015bb86ada0e871c413a4ecdc903a3785ca | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 198 | 114 | 6 | 38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 199 | 114 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.22e-05 | 150 | 114 | 5 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.74e-05 | 160 | 114 | 5 | 9049707a4487f2337a17976ceb5fbd8815ab9e1d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.74e-05 | 160 | 114 | 5 | f2cfec54cf48a655f473b830be7d141c54b521ff | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.74e-05 | 160 | 114 | 5 | 0eb50b3c494e1b65d40104b3b5411b57bb72b959 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 5.91e-05 | 161 | 114 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 165 | 114 | 5 | 9de841c1c95967c562720feba930246debc626fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 165 | 114 | 5 | a612a7d3a5415ecacc3df8fbff0ce498f982aad0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 165 | 114 | 5 | cdc94a640ec01c6892521bcd6f0ee0a66ff23866 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 166 | 114 | 5 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.23e-05 | 168 | 114 | 5 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 169 | 114 | 5 | 2a35846b0e0be0a19a5a04a86cbd72ce65257c8a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.64e-05 | 170 | 114 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 170 | 114 | 5 | 067657ca7fcf5a0ffbd168b5c4609a30ca508f22 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 7.86e-05 | 171 | 114 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.08e-05 | 172 | 114 | 5 | 18bdf34e1b94dcb1daf00c533e3ce1a8d67fcc0e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.08e-05 | 172 | 114 | 5 | 41ddfb316429efef5f3fa0b0621ced383d9206f0 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.30e-05 | 173 | 114 | 5 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.30e-05 | 173 | 114 | 5 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | a37f38478473290fe35aea8684befc3bf95b161f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | 889a880de5fc19d26b82cfef3067869a28ef17ca | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.30e-05 | 173 | 114 | 5 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.53e-05 | 174 | 114 | 5 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.00e-05 | 176 | 114 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-05 | 176 | 114 | 5 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.00e-05 | 176 | 114 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.49e-05 | 178 | 114 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.49e-05 | 178 | 114 | 5 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.75e-05 | 179 | 114 | 5 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-05 | 179 | 114 | 5 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-05 | 179 | 114 | 5 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-04 | 181 | 114 | 5 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 181 | 114 | 5 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 181 | 114 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 181 | 114 | 5 | b9fe3833a6a56b9fbe5c257393fdbea5bf8ac4a3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 183 | 114 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 183 | 114 | 5 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 183 | 114 | 5 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 183 | 114 | 5 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.08e-04 | 183 | 114 | 5 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 183 | 114 | 5 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.08e-04 | 183 | 114 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-04 | 184 | 114 | 5 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 184 | 114 | 5 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|normal_Lung / Location, Cell class and cell subclass | 1.11e-04 | 184 | 114 | 5 | 7ee98acda030366ac6cf3890a6d93fd0426712ed | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 184 | 114 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 184 | 114 | 5 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 184 | 114 | 5 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.11e-04 | 184 | 114 | 5 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-04 | 184 | 114 | 5 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 114 | 5 | 7092436b4db90289516ed130ade596e3021cffaf | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A | 5.90e-07 | 194 | 114 | 9 | 6921_UP | |
| Drug | PtdIns(3)P | 2.86e-06 | 175 | 114 | 8 | CID000643964 | |
| Drug | Doxepin hydrochloride [1229-29-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 6.85e-06 | 197 | 114 | 8 | 7415_UP | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 5.07e-05 | 19 | 113 | 3 | OBA_2045199 | |
| Disease | Heschl's gyrus morphology measurement | 5.17e-05 | 53 | 113 | 4 | EFO_0005852 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 9.16e-05 | 23 | 113 | 3 | OBA_2045158 | |
| Disease | level of Phosphatidylcholine (16:0_18:0) in blood serum | 2.16e-04 | 6 | 113 | 2 | OBA_2045069 | |
| Disease | level of Phosphatidylcholine (16:1_20:4) in blood serum | 2.16e-04 | 6 | 113 | 2 | OBA_2045084 | |
| Disease | resting heart rate | 2.78e-04 | 149 | 113 | 5 | EFO_0004351 | |
| Disease | level of Phosphatidylcholine (O-18:2_18:1) in blood serum | 3.01e-04 | 7 | 113 | 2 | OBA_2045133 | |
| Disease | lysophosphatidylcholine 22:4 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0021461 | |
| Disease | phosphatidylcholine 35:5 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0021472 | |
| Disease | cholesteryl ester 24:4 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0021447 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_18:2) in blood serum | 4.01e-04 | 8 | 113 | 2 | OBA_2045147 | |
| Disease | phosphatidylcholine 39:5 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0021476 | |
| Disease | level of Phosphatidylcholine (18:2_20:1) in blood serum | 5.14e-04 | 9 | 113 | 2 | OBA_2045107 | |
| Disease | level of Phosphatidylcholine (O-18:0_20:4) in blood serum | 5.14e-04 | 9 | 113 | 2 | OBA_2045127 | |
| Disease | level of Phosphatidylcholine (O-18:1_18:2) in blood serum | 5.14e-04 | 9 | 113 | 2 | OBA_2045129 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 5.14e-04 | 9 | 113 | 2 | OBA_2045130 | |
| Disease | level of Phosphatidylcholine (16:0_20:5) in blood serum | 5.14e-04 | 9 | 113 | 2 | OBA_2045077 | |
| Disease | level of Phosphatidylcholine (18:0_20:5) in blood serum | 5.14e-04 | 9 | 113 | 2 | OBA_2045095 | |
| Disease | phosphatidylethanolamine measurement | 5.51e-04 | 173 | 113 | 5 | EFO_0010228 | |
| Disease | information processing speed, cognitive function measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0004363, EFO_0008354 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 6.41e-04 | 10 | 113 | 2 | cv:C4707243 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_20:4) in blood serum | 6.41e-04 | 10 | 113 | 2 | OBA_2045148 | |
| Disease | cholesteryl ester 22:4 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0021443 | |
| Disease | cholesteryl ester 22:5 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0021444 | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 6.41e-04 | 10 | 113 | 2 | OBA_2045075 | |
| Disease | urate measurement | RERG DNAH3 CHST1 CXXC1 FADS3 LRP1 LRP2 FADS2 UHRF1 ADGRL2 FAIM2 | 6.57e-04 | 895 | 113 | 11 | EFO_0004531 |
| Disease | QRS complex, QRS duration | 6.90e-04 | 45 | 113 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | level of Phosphatidylcholine (O-16:1_20:4) in blood serum | 7.82e-04 | 11 | 113 | 2 | OBA_2045123 | |
| Disease | lysophosphatidylcholine 20:2 measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0021458 | |
| Disease | cholesteryl ester 20:3 measurement | 8.86e-04 | 49 | 113 | 3 | EFO_0010347 | |
| Disease | cholesteryl ester 20:2 measurement | 9.36e-04 | 12 | 113 | 2 | EFO_0021440 | |
| Disease | cholesteryl ester 24:5 measurement | 9.36e-04 | 12 | 113 | 2 | EFO_0021448 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.08e-03 | 117 | 113 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:4) in blood serum | 1.10e-03 | 13 | 113 | 2 | OBA_2045116 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 1.10e-03 | 13 | 113 | 2 | OBA_2045072 | |
| Disease | household income | 1.14e-03 | 304 | 113 | 6 | EFO_0009695 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 1.28e-03 | 14 | 113 | 2 | OBA_2045100 | |
| Disease | level of Phosphatidylcholine (18:1_20:2) in blood serum | 1.28e-03 | 14 | 113 | 2 | OBA_2045102 | |
| Disease | diacylglycerol 38:4 measurement | 1.28e-03 | 14 | 113 | 2 | EFO_0020066 | |
| Disease | cis/trans-18:2 fatty acid measurement, trans fatty acid measurement | 1.48e-03 | 15 | 113 | 2 | EFO_0006821, EFO_0006824 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 1.48e-03 | 15 | 113 | 2 | EFO_0800508 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 1.48e-03 | 15 | 113 | 2 | OBA_2045131 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.48e-03 | 15 | 113 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | hypertension (implicated_via_orthology) | 1.51e-03 | 128 | 113 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | intracerebral hemorrhage | 1.68e-03 | 16 | 113 | 2 | EFO_0005669 | |
| Disease | Intellectual Disability | 1.70e-03 | 447 | 113 | 7 | C3714756 | |
| Disease | Global developmental delay | 1.74e-03 | 133 | 113 | 4 | C0557874 | |
| Disease | lateral occipital cortex volume measurement | 1.90e-03 | 17 | 113 | 2 | EFO_0010311 | |
| Disease | sphingosine 1-phosphate measurement | 2.14e-03 | 18 | 113 | 2 | EFO_0800185 | |
| Disease | phosphatidylcholine 36:4 measurement | 2.14e-03 | 18 | 113 | 2 | EFO_0010382 | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 2.14e-03 | 18 | 113 | 2 | OBA_2045110 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 2.14e-03 | 18 | 113 | 2 | OBA_2045079 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.20e-03 | 346 | 113 | 6 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | diacylglycerol 38:5 measurement | 2.38e-03 | 19 | 113 | 2 | EFO_0020067 | |
| Disease | diacylglycerol 38:3 measurement | 2.38e-03 | 19 | 113 | 2 | EFO_0020065 | |
| Disease | Pheochromocytoma | 2.38e-03 | 19 | 113 | 2 | C0031511 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 2.64e-03 | 20 | 113 | 2 | OBA_2045071 | |
| Disease | Alzheimer disease | 2.69e-03 | 485 | 113 | 7 | MONDO_0004975 | |
| Disease | gait measurement | 2.69e-03 | 150 | 113 | 4 | EFO_0007680 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 2.91e-03 | 21 | 113 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 2.91e-03 | 21 | 113 | 2 | OBA_2045156 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 2.91e-03 | 21 | 113 | 2 | OBA_2045076 | |
| Disease | PR interval | 3.01e-03 | 495 | 113 | 7 | EFO_0004462 | |
| Disease | nucleus accumbens volume | 3.19e-03 | 22 | 113 | 2 | EFO_0006931 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 3.49e-03 | 23 | 113 | 2 | C1708353 | |
| Disease | phosphatidylserines measurement | 3.49e-03 | 23 | 113 | 2 | EFO_0020049 | |
| Disease | age at first sexual intercourse measurement | 3.63e-03 | 383 | 113 | 6 | EFO_0009749 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ANO4 ARHGAP15 BRINP1 DNAAF3 SEMA6D SND1 PLEKHA5 ADGRL2 USH2A | 3.72e-03 | 801 | 113 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILRLVDSAYKRRQEW | 731 | Q9BWT7 | |
| ESTREEKERWIRSKY | 421 | Q8TF27 | |
| YERSFLREFHKWIER | 281 | Q9UJX6 | |
| IYREFARWKVRNTAI | 71 | O60477 | |
| REMHVWREVFYRLER | 111 | Q7LC44 | |
| VKIFSSRDERSWFRE | 221 | Q8NER5 | |
| LRFEATWETVYDKRA | 296 | O95490 | |
| SREERESWIRAKYEQ | 1026 | Q99490 | |
| ERYKALVRWIDDESS | 306 | Q86W34 | |
| RLEYRQRWDEAFRKF | 181 | P27695 | |
| FLEFWKRRRAVIAYD | 441 | Q32M45 | |
| KRRRAVIAYDWDLID | 446 | Q32M45 | |
| YSDDSKIWRPVEIFR | 101 | Q9H7Y0 | |
| KRDTLWLALRETVYD | 1336 | A7MBM2 | |
| VEEFRKDFISRIWLT | 76 | Q96DT6 | |
| KDFISRIWLTYREEF | 81 | Q96DT6 | |
| DVVTRTNKIRDRFWD | 471 | Q8IZY2 | |
| KRRRSILTYTWDLIE | 491 | Q9BYT9 | |
| EIRLDAYKFVTQWRR | 786 | Q9BYT9 | |
| RTGRYTLIEKWRDTE | 36 | Q8NHQ8 | |
| EILFKERAKLYRWDR | 2931 | P49792 | |
| RRSYEIMFREEFWRR | 1456 | P98160 | |
| RFRTRAYRRAAEKWE | 746 | Q92621 | |
| LRTDRWLVIDRKVYN | 31 | O95864 | |
| ESRSWFFERINKIDR | 361 | O00370 | |
| FRWAERYRLAEPTEK | 1276 | Q9NU22 | |
| EKRIVWTDARSDAIY | 1436 | Q9NZR2 | |
| FSWDDQKVRRVFVRK | 91 | Q9BWQ8 | |
| SEPRAREVVDWRKYE | 436 | P46199 | |
| ERRELKIQERTYSLW | 446 | Q9Y216 | |
| RVWAAIRDKYRSEAL | 271 | P14314 | |
| VDYLEKRILWIDARS | 1441 | Q07954 | |
| LYWCDARTDKIERID | 2066 | Q07954 | |
| SEEEFKLWNRLYRLR | 681 | Q8IYD8 | |
| REREVKLWDTRFFSS | 236 | P57737 | |
| STYREIGRRLKFWNE | 66 | P24071 | |
| RPVKFWERDYNTKRV | 1516 | Q96RV3 | |
| VFTATRYEDRRAEWV | 436 | Q16549 | |
| WRLKYERAVREVDFT | 1371 | Q92614 | |
| VSTRERYKWLRFSED | 101 | Q5XG92 | |
| IDEYSRAVRDVKTDW | 336 | Q9H706 | |
| NEAKRRVRELYRAWY | 26 | P56556 | |
| EFLRIKYWDRRRRAA | 521 | Q8NA70 | |
| RRTVERYDTEKDEWT | 396 | Q8IY47 | |
| RWEEVQSYIRKRTAE | 496 | Q86UP2 | |
| IDVFFRQSWKDERLR | 96 | P31644 | |
| ALDFDRVEKRLYWID | 3231 | P98164 | |
| TDRDWRIFREDYSIT | 366 | Q9BUQ8 | |
| SWIVKRSYEDFRVLD | 166 | A7KAX9 | |
| ERDEYKRRWEEEYTV | 251 | Q0D2I5 | |
| RDEAKLIAVEIYRWI | 181 | Q14008 | |
| YCWEKLRRAEVDLER | 591 | Q9P0U4 | |
| LRRAEVDLERVRVWY | 596 | Q9P0U4 | |
| VDLERVRVWYKLDEL | 601 | Q9P0U4 | |
| YALTVWRFFRDRTEE | 236 | O60725 | |
| EAVMRWVYRAVDLRR | 231 | Q6TFL4 | |
| FRERDALEAVFRFWA | 161 | Q8N9W5 | |
| ELWFAEFRDLRFVRT | 356 | Q8TD57 | |
| LERTAFRKDSQRWYV | 1081 | Q14CM0 | |
| EAWKTYTERRNALRE | 36 | Q9BVV2 | |
| RAWRDYTRFQKLERE | 361 | Q8NCU4 | |
| KETRWKYHFEVVRDT | 261 | O95395 | |
| RTYESKEEARWRLSV | 196 | Q9UBX1 | |
| ITVWYFDADERARAK | 386 | Q9GZT9 | |
| YHRADVEKVLRRWVD | 186 | Q8WWZ3 | |
| LRTRDETYIWEKITD | 101 | Q8N7A1 | |
| WDTKDIYRQRSRALV | 141 | Q12794 | |
| RARYLAEKYEWDVAE | 631 | P13639 | |
| DKWLVIERRVYDISR | 36 | Q9Y5Q0 | |
| CYYIGKERRTWEERV | 131 | O43908 | |
| VEALAKATYERLFRW | 421 | P35580 | |
| EWSRREAERLVKYRE | 116 | Q9NX14 | |
| REVEEFLYRAVKRRW | 236 | Q8N344 | |
| TSEERTRWAKAREYL | 241 | Q9UKG9 | |
| RYEIRWKVIESVSSD | 561 | P09619 | |
| LVKEVAAWRERYEDS | 806 | Q14980 | |
| ERWSDALIKRREYLD | 1096 | Q9H1H9 | |
| IRYEVIRRCFEGKAW | 4186 | O75445 | |
| IQAEEWYFGKITRRE | 146 | P12931 | |
| WYFGKITRRESERLL | 151 | P12931 | |
| YEAFCRWREVSAKER | 106 | P51649 | |
| IYSPEKREEAWRFIS | 111 | Q9NX52 | |
| FFRRIDWEKLENREI | 596 | P17252 | |
| KTRVRFFRLDRWADV | 71 | Q9HCE1 | |
| WVELKDDRIETYVRT | 641 | Q8TC59 | |
| FFLRDITLRYKETRW | 431 | Q9BVG9 | |
| WELLFYREVSEDRRQ | 2991 | P58107 | |
| VWELLFYREVSEDRR | 3521 | P58107 | |
| WELLFYREVSEDRRQ | 4056 | P58107 | |
| WIVLSSRRIEFYKES | 106 | Q53QZ3 | |
| TRERLYEWISIDKDE | 881 | O15357 | |
| RFAKERRLRIWRDYV | 316 | Q7KZF4 | |
| TESEKYRVVLRRWKS | 216 | Q9P0P8 | |
| SEFEVRRRYQDFLWL | 66 | Q9UNH6 | |
| ALVVRFLTKRFIWEY | 21 | Q96A58 | |
| RILFLDDKRCEWIYR | 376 | Q15047 | |
| VKIFSSREERSWFRE | 231 | P36897 | |
| ATYRSLVAREKVFWD | 51 | Q9UBY8 | |
| TAEKWRFRLSYDIVA | 356 | O43916 | |
| VEALAKATYERLFRW | 421 | P35749 | |
| KATYERLFRWILTRV | 426 | P35749 | |
| TWRNVAERTEKVYDR | 386 | P37287 | |
| WEEYIIRTLSRVEFL | 236 | Q5T1Q4 | |
| EVFRELTDVRRYWVD | 286 | Q9C035 | |
| ERDKRVTWIVEFFAN | 151 | Q9Y320 | |
| KWAYERVEERFERIP | 76 | Q9P217 | |
| RDWLRVVASDKETYE | 91 | Q6P5R6 | |
| RRYQDFDWLRSKLEE | 131 | Q5VWJ9 | |
| FRVSWKDRDRDVIFL | 166 | O95155 | |
| DEIRSQYRADWKSRE | 291 | Q969P6 | |
| RRYAWIKRQLVDYEE | 286 | Q5VIR6 | |
| WERYTHRRKEVSEEN | 1006 | Q9H2K2 | |
| RWALDREQREKYELV | 226 | P07949 | |
| SIFSRVEEDYLWRIK | 1191 | Q9UBW7 | |
| GFWYDAEISRKRETR | 236 | Q96T88 | |
| RVWSLEESRYLQREK | 121 | Q6AWC8 | |
| GWEKRVDSTDRVYFV | 461 | Q9H0M0 | |
| ATAELERAWREYDKL | 711 | Q9HAU0 | |
| ERAWREYDKLEYDVT | 716 | Q9HAU0 | |
| IADEPWFTKTRVRYR | 406 | Q8NFY4 | |
| EESWVVFRRYTDFSR | 136 | P57768 | |
| IEEEKYTTRQDWDLR | 21 | O43309 | |
| ERRWDLDLTYVTERI | 126 | Q63HR2 | |
| DDVDRTLDEWKRVTY | 331 | P53778 | |
| KWDYVERQLRDYDRI | 261 | Q8N145 | |
| RWVTFLLKIYRAEDI | 356 | Q9NZM1 | |
| ELAYEIFDKGRVRFW | 1021 | P54296 |